Charles River Laboratories International (CRL) Total Current Liabilities (2009 - 2025)

Charles River Laboratories International's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $1.1 billion for Q4 2025.

• In Q4 2025, Total Current Liabilities rose 12.7% year-over-year to $1.1 billion; the TTM figure through Dec 2025 stood at $1.1 billion (up 12.7% YoY), while the FY2025 annual figure was $1.1 billion, up 12.7% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $1.1 billion, roughly flat from $1.1 billion in the prior quarter.
• The five-year high for Total Current Liabilities was $1.1 billion in Q3 2025, with the low at $803.4 million in Q1 2021.
• The 5-year median for Total Current Liabilities is $1.0 billion (2023), against an average of $1.0 billion.
• The sharpest annual moves came in 2021 and 2024: Total Current Liabilities climbed 27.7% in 2021, then declined 5.96% in 2024.
• Charles River Laboratories International's Total Current Liabilities stood at $1.0 billion in 2021, then increased by 5.65% to $1.1 billion in 2022, then declined by 3.34% to $1.1 billion in 2023, then declined by 5.78% to $994.1 million in 2024, then grew by 12.7% to $1.1 billion in 2025.
• Business Quant data shows CRL's Total Current Liabilities at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.